Risk reclassification of endometrial cancer according to molecular profiling: UK single centre experience. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback